Group One Trading’s Jasper Therapeutics JSPR Stock Holding History
Bought
Maintained
Sold
Other funds holding JSPR
OM
ACA
KCM
Group One Trading's JSPR Position: Q3 2026 in Review
Group One Trading held its Jasper Therapeutics (JSPR) position steady in Q3 2026 at 664 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6218.
Group One Trading first reported a position in JSPR in Q2 2022 and has held it in 10 quarters since. The position peaked at $41.8K in Q3 2025. 50 funds tracked by Wall St. Rank hold JSPR as of Q3 2026.
- Group One Trading held 664 shares of Jasper Therapeutics worth $11.6K as of Q3 2026.
- Group One Trading left its Jasper Therapeutics share count unchanged in Q3 2026.
- Jasper Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #6218 holding.
- Group One Trading first reported a position in Jasper Therapeutics in Q2 2022 and has held it in 10 quarters since.
- Group One Trading's Jasper Therapeutics position peaked at $41.8K in Q3 2025.
- 50 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.